These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10816339)

  • 1. Comprehensibility of the package leaflets of all medicinal products for human use: a questionnaire survey about the use of symbols and pictograms.
    Bernardini C; Ambrogi V; Perioli LC; Tiralti MC; Fardella G
    Pharmacol Res; 2000 Jun; 41(6):679-88. PubMed ID: 10816339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to improve the readability of the patient package leaflet: a survey on the use of colour, print size and layout.
    Bernardini C; Ambrogi V; Fardella G; Perioli L; Grandolini G
    Pharmacol Res; 2001 May; 43(5):437-44. PubMed ID: 11394935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do pictograms improve children's understanding of medicine leaflet information?
    Hämeen-Anttila K; Kemppainen K; Enlund H; Bush Patricia J; Marja A
    Patient Educ Couns; 2004 Dec; 55(3):371-8. PubMed ID: 15582343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The situation of OTC drugs in italy compared to the other EU states.
    Minghetti P; Casiraghi A; Cilurzo F; Montanari L
    Pharmacol Res; 2000 Jul; 42(1):25-31. PubMed ID: 10860631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient information leaflets--patients' comprehension of information about interactions and contraindications.
    Gustafsson J; Kälvemark S; Nilsson G; Nilsson JL
    Pharm World Sci; 2005 Feb; 27(1):35-40. PubMed ID: 15861933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of the Patient Information Leaflet in Patients'Medication Therapy: A Case Study within the Kumasi Metropolis of Ghana.
    Owusu FWA; Yeboah GN; Aboagye RA; Amengor CDK; Entsie P
    ScientificWorldJournal; 2020; 2020():2489137. PubMed ID: 33149725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' use and perception of medication information leaflets.
    Nathan JP; Zerilli T; Cicero LA; Rosenberg JM
    Ann Pharmacother; 2007 May; 41(5):777-82. PubMed ID: 17405820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of the comprehension of new rephrasing drug package inserts].
    Miquel AV; Ortín Font F; Marrugat J; Pavesi M
    Med Clin (Barc); 2000 Oct; 115(11):410-7. PubMed ID: 11093843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Planning a statistical inquiry for evaluation of patient information].
    Bernardini C; Ambrogi V; Fardella G; Perioli L; Tiralti MC; Ballatori E
    Boll Chim Farm; 1999 Mar; 138(3):57-67. PubMed ID: 10394704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients in need of medicine information.
    Kazaryan I; Sevikyan A
    Int J Risk Saf Med; 2015; 27 Suppl 1():S21-2. PubMed ID: 26639693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
    Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of front-of-pack nutrition symbols: a pilot study with consumers.
    Emrich TE; Mendoza JE; L'Abbé MR
    Can J Diet Pract Res; 2012; 73(4):200-3. PubMed ID: 23217449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Patient information leaflets seen through the eyes of patients in a general practice].
    Horwitz A; Reuther L; Andersen SE
    Ugeskr Laeger; 2009 Feb; 171(8):599-602. PubMed ID: 19284903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpretations of a teratogen warning symbol.
    Daniel KL; Goldman KD; Lachenmayr S; Erickson JD; Moore C
    Teratology; 2001 Sep; 64(3):148-53. PubMed ID: 11514945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Evaluation of Medication Package Leaflets in Al Kharj City, Saudi Arabia.
    Alaqeel S; Al Obaidi N
    Ther Innov Regul Sci; 2017 Jan; 51(1):45-50. PubMed ID: 30235994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inappropriate dosage instructions in package inserts.
    Fuchs J; Hippius M
    Patient Educ Couns; 2007 Jul; 67(1-2):157-68. PubMed ID: 17451909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug information for patients (Package Leaflets), and user testing in EU].
    Yamamoto M; Doi H; Furukawa A
    Yakugaku Zasshi; 2015; 135(2):277-84. PubMed ID: 25747226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of drug information leaflets on patient behavior.
    Vinker S; Eliyahu V; Yaphe J
    Isr Med Assoc J; 2007 May; 9(5):383-6. PubMed ID: 17591379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient information leaflets: friend or foe?
    Pines A
    Climacteric; 2015 Oct; 18(5):663-5. PubMed ID: 25668438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory agencies' recommendations for medicine information leaflets: Are they in line with research findings?
    Young A; Tordoff J; Smith A
    Res Social Adm Pharm; 2018 Feb; 14(2):196-202. PubMed ID: 28285793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.